Return to homepagePandemic Pact

Molecular design, synthesis and screening for anticoronavirus activity of nanoencapsulated heterocyclic compounds with controlled cellular toxicity (COVIDAvir)

Grant number: KP-06-K3 / 2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $120,000

  • Funder

    NSF Bulgaria

  • Principal Investigator

    Assoc Prof Dr Meglena Kandinska Vasileva

  • Research Location

    Bulgaria

  • Lead Research Institution

    Sofia University "St. Kliment Ohridski"

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract